Baseline | Week 12 | Difference between before and after treatment | SES | SRM | ||||
---|---|---|---|---|---|---|---|---|
x - ± SD | x - ± SD | x - ± SD | P | T | 95% CI | |||
Primary bothersome symptom | 7.00 ± 2.27 | 3.87 ± 2.52 | 3.13 ± 2.97 | <0.001 | 13.45 | 2.67-3.59 | 1.38 | 1.05 |
Secondary bothersome symptom | 6.37 ± 2.38 | 3.42 ± 2.45 | 2.95 ± 2.96 | <0.001 | 12.72 | 2.49-3.41 | 1.24 | 1.00 |
ZRADSQ | 15.12 ± 6.58 | 8.63 ± 5.66 | 6.48 ± 6.14 | <0.001 | 13.48 | 5.53-7.43 | 0.98 | 1.06 |
SCORAD | 48.34 ± 15.66 | 26.97 ± 15.76 | 21.36 ± 15.22 | <0.001 | 17.93 | 19.01-23.72 | 1.36 | 1.40 |